Covid-19
Conditions
Keywords
nutritional status, malnutrition, diet intervention, sarcopenia, muscle strength
Brief summary
Coronavirus infection is responsible for muscle wasting (sarcopenia), especially during prolonged stays in intensive care. Sarcopenia, in its functional aspect also seems major in patients hospitalized for this infection, in non-ICU unit. Weight loss also appears to be significant, despite a prevalence of overweight and obesity in severe forms. Undernutrition in the obese patient is also possible (undernourished obese and sarcopenia obesity). Anosmia and dysgeusia participate in undernutrition by reducing energy intake. The rehabilitation of these patients requires nutritional support (increased protein intake) associated with progressive retraining to physical activity. An early and proactive management procedure within Coronavirus disease-19 units has been implemented in conjunction with the Transversal Nutrition Unit (TNU). This nutritional care must be continued after discharge. Follow-up by teleconsultation or telephone consultation is put in place after the patient's discharge Primary Objective: Evaluation of nutritional status at the time of admission and discharge and home follow-up in outgoing patients from Coronavirus disease-19 Units Secondary objectives: Description of the evolution of food intake, diversity of food and coverage of needs Evaluation of the muscular strength of the wrist (by grip test in hospital) and on the arms and legs after return home (visual analog scale) Evolution of anosmia and dysgeusia (at the time of hospital admission, at the time of hospital discharge and at home) Level of physical training before infection (IPAQ) Description of the general state of health measured by the performance index - world health organization scale Description of nutritional prescriptions Description of the prevention measures and incidence of Inappropriate Refeeding Syndrome (IRS) Care needs assessments
Interventions
nutritional evaluation and intervention and orientation towards adapted care establishment
Sponsors
Study design
Eligibility
Inclusion criteria
* Covid positive (RT-PCR)
Exclusion criteria
* Unable to answer questions by telephone or teleconsultation directly or through a relative, minors under 16 years of age
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| nutritional evaluation | before Covid, at hospital discharge and between 7 and 45 days after discharge | weight |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| muscle strenght | at the time of hospital admission and at the time of hospital discharge | hand grip |
| food intake | at the time of hospital admission, at the time of hospital discharge | Caloric account |
| biological nutritional status | at the time of hospital admission, at the time of hospital discharge | albuminemia transthyretinemia electrolytes dosage inflammation status |
| anosmia | at the time of hospital admission, at the time of hospital discharge and between 7 and 45 days after discharge | anosmia and agueusia evolution |
Countries
France